31.7 C
New York
Sunday, June 14, 2026

Tag: cardiovascular

Fruit and Vegetables Market Size Projected to Surpass USD 388.37 Billion by 2034, Backed by Organic and Fresh Produce Demand

According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034.
According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034.

Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting

The cell therapy market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments,...

Cell Therapy Market to Reach USD 29.5 Billion by 2032, Growing at 21.5% CAGR | SkyQuest Technology Consulting

The cell therapy market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments,...

Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott

The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leading players like Medtronic and Philips are instrumental in market expansion through innovations and strategic partnerships across Europe.
The Europe defibrillator market, valued at USD 3.87 billion in 2024, is projected to reach USD 7.23 billion by 2033, with a CAGR of 7.2%. Growth drivers include rising cardiovascular diseases, technological advancements, and government initiatives to expand public defibrillator access. Key segments include implantable and external defibrillators with significant usage in hospitals, public, and home settings. The market faces challenges such as high device costs and regulatory complexities. Leading players like Medtronic and Philips are instrumental in market expansion through innovations and strategic partnerships across Europe.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCardiovascular